News
Stay up to date
Follow the latest on our journey, as we are living innovation!
At Galapagos, we are united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life across the globe
Focusing on high unmet medical needs, we synergize the most compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class therapies. With capabilities from lab to patient, including a decentralized T-cell manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
Our mission is to accelerate transformational innovation through the relentless pursuit of groundbreaking science, our entrepreneurial spirit and a collaborative mindset. In 2022, we entered the field of oncology, CAR-T, and biologicals and development with the acquisitions of CellPoint and AboundBio. These transactions have provided us with end-to-end CAR-T development capabilities, with the potential to change the paradigm in the field by implementing a groundbreaking decentralized T-cell manufacturing platform and state-of-the-art fully human antibody-based capabilities for the development of next-generation CAR-Ts and biologics.
Meet the members of our Executive Committee and our Management Team. They are driving innovation to deliver life-changing treatments for patients worldwide, together.
PIPELINE
We focus on delivering best-in-class medicines with transformational impact for patients by accelerating life-changing science and innovation in the fields of immunology and oncology.
Your career at Galapagos
Do you want to pioneer for patients with us? Consider this your call for purpose, and apply today!
News
Follow the latest on our journey, as we are living innovation!
Investors
Looking for the latest presentations, upcoming events, and financial highlights?